1 – 71 of 71
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Amidst an amygdala renaissance in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Inhibiting metabotropic glutamate receptor 5 after stroke restores brain function and connectivity
(
- Contribution to journal › Article
-
Mark
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
(
- Contribution to journal › Article
- 2023
-
Mark
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
(
- Contribution to journal › Article
-
Mark
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Age-related and amyloid-beta-independent tau deposition and its downstream effects
(
- Contribution to journal › Article
- 2022
-
Mark
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid is a significant fluid source for anoxic cerebral oedema
(
- Contribution to journal › Article
-
Mark
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(
- Contribution to journal › Article
-
Mark
Genetically identical twins show comparable tau PET load and spatial distribution
(
- Contribution to journal › Article
- 2021
-
Mark
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy
(
- Contribution to journal › Article
- 2020
-
Mark
Cerebrospinal fluid tau fragment correlates with tau PET : a candidate biomarker for tangle pathology
(
- Contribution to journal › Article
-
Mark
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A clinical-radiological framework of the right temporal variant of frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles
(
- Contribution to journal › Article
-
Mark
Relationship between cortical iron and tau aggregation in Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Genome-wide association study of cerebral small vessel disease reveals established and novel loci
(
- Contribution to journal › Article
-
Mark
Alzheimer's pathology targets distinct memory networks in the ageing brain
(
- Contribution to journal › Article
-
Mark
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Will FTLD-tau work for all when FTDP-17 retires?
(
- Contribution to journal › Article
- 2017
-
Mark
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.
(
- Contribution to journal › Article
-
Mark
Embodied neurology: an integrative framework for neurological disorders
(
- Contribution to journal › Article
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
NEK1 mutations in familial amyotrophic lateral sclerosis.
(
- Contribution to journal › Letter
- 2015
-
Mark
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
(
- Contribution to journal › Article
-
Mark
Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
(
- Contribution to journal › Article
-
Mark
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
(
- Contribution to journal › Article
-
Mark
Cortical burst dynamics predict clinical outcome early in extremely preterm infants.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
The role of tau in the pathological process and clinical expression of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
- 2014
-
Mark
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
(
- Contribution to journal › Article
-
Mark
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
(
- Contribution to journal › Article
- 2013
-
Mark
Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery.
(
- Contribution to journal › Article
-
Mark
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article
- 2012
-
Mark
Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin
(
- Contribution to journal › Article
- 2011
-
Mark
GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
(
- Contribution to journal › Article
- 2010
-
Mark
The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
(
- Contribution to journal › Article
- 2009
-
Mark
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
(
- Contribution to journal › Article
-
Mark
Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
(
- Contribution to journal › Article
- 2008
-
Mark
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Upper limb amputees can be induced to experience a rubber hand as their own
(
- Contribution to journal › Article
- 2007
-
Mark
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis
(
- Contribution to journal › Article
-
Mark
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
(
- Contribution to journal › Article
-
Mark
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
(
- Contribution to journal › Article
- 2006
-
Mark
TGF beta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis
(
- Contribution to journal › Article
- 2005
-
Mark
Multipotent progenitor cells from the adult human brain: neurophysiological differentiation to mature neurons
(
- Contribution to journal › Article
-
Mark
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
(
- Contribution to journal › Article
-
Mark
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
(
- Contribution to journal › Article
-
Mark
Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group
(
- Contribution to journal › Article
- 2003
-
Mark
Vibration-induced ocular torsion and nystagmus after unilateral vestibular deafferentation.
(
- Contribution to journal › Article
- 2002
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(
- Contribution to journal › Letter
-
Mark
Adenosine A(1) receptor agonists inhibit trigeminovascular nociceptive transmission
(
- Contribution to journal › Article
- 2000
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article